Aurora Cannabis Inc.
NASDAQ:ACBDrug Manufacturers - Specialty & Generic
+$0.02 today
- Market cap
- $289.28M
- Beta
- 1.34
- P/E (TTM)
- -3.2
- EPS (TTM)
- -$1.31
Volume 0.92M
Average 1.00M
ACB Total Assets
Everything the company owns or controls; equal to total liabilities plus equity.
Aurora Cannabis Inc.NASDAQ: ACB
Total Assets · Q4 FY2026 · quarter ended Mar 2026
Total assets falls 28.9% from a year ago
Total assets stood at CA$602.64M at the end of Q4 FY2026, down 28.9% from a year earlier and down 22.3% from the prior quarter. Over 3 fiscal years it compounded at -13.4% a year.
Context
- Total assets increased in 1 of the last 3 fiscal years.
- FY2026 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether total assets keeps falling in the next quarterly balance sheet after a -28.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Assets history
CAD · from the balance sheet
- Latest · FY2026
- 602.64M CAD
- Year-over-year change
- -28.9%
- 4-year CAGR
- -10.2%
| Period | Period end | Total Assets | YoY change |
|---|---|---|---|
| FY2026 | 2026-03-31 | 602.64M | -28.9% |
| FY2025 | 2025-03-31 | 847.77M | +0.9% |
| FY2024 | 2024-03-31 | 840.14M | -9.3% |
| FY2023 | 2023-03-31 | 926.38M | +0.0% |
| FY2022 | 2022-06-30 | 926.38M | — |
Total Assets vs competitors
How ACB compares with its peers on the latest reported figures
- Peers report in different currencies, so total assets is compared through growth and rates rather than absolute size.
- Its year-over-year change of -28.9% is the 9th highest of 10, against a peer median of +0.3%.
- Over three fiscal years its annual growth of -13.4% compares with a peer median of -12.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR |
|---|---|---|---|---|
| Mar 2026 | CA$1.12B CAD | +21.9% | -13.8% | |
| Mar 2026 | CA$602.64M CAD | -28.9% | -13.4% | |
| Mar 2026 | CA$522.66M CAD | -2.8% | — | |
| Mar 2026 | $434.57M USD | +32.8% | -28.8% | |
BIOABioAge Labs, Inc. | Mar 2026 | $397.65M USD | +15.7% | +118.1% |
| Apr 2026 | CA$347.75M CAD | +49.9% | +8.3% | |
| Dec 2025 | $232.18M USD | — | — | |
| Mar 2026 | $198.72M USD | +0.3% | -14.3% | |
| Mar 2026 | $149.34M USD | -43.4% | -28.7% | |
| Mar 2026 | $98.66M USD | -13.5% | -12.1% | |
| Mar 2026 | $70.12M USD | -4.7% | +40.0% | |
| Peer median (excluding ACB) | — | +0.3% | -12.9% | |
Competitors are the stored peer set for ACB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2022 Jun 2022 | FY2023 Mar 2023 | FY2024 Mar 2024 | FY2025 Mar 2025 | FY2026 Mar 2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | 300.86M | 300.86M | 179.53M | 184.26M | 112.77M |
| Short-term Investments | 0 | 0 | 4.04M | 550.82K | 52.35M |
| Net Receivables | 41.35M | 41.35M | 45.49M | 42.23M | 44.69M |
| Inventory | 128.83M | 128.83M | 186.7M | 237.72M | 175.53M |
| Other Current Assets | 8.92M | 8.92M | 11.58M | 10.82M | 13.14M |
| Total Current Assets | 479.96M | 479.96M | 427.35M | 475.58M | 398.48M |
| Property, Plant & Equipment (Net) | 322.99M | 322.99M | 294.84M | 266.57M | 124.01M |
| Goodwill | 18.72M | 18.72M | 43.26M | 43.62M | 26.72M |
| Intangible Assets | 59.68M | 59.68M | 40.92M | 44.9M | 31.52M |
| Long-term Investments | 13.75M | 13.75M | 6.35M | 5.23M | 15.82M |
| Tax Assets | 15.5M | 15.5M | 15.37M | 4.19M | 2.46M |
| Other Non-current Assets | 15.79M | 15.79M | 12.05M | 7.68M | 3.63M |
| Total Non-current Assets | 446.42M | 446.42M | 412.79M | 372.19M | 204.16M |
| Total Assets | 926.38M | 926.38M | 840.14M | 847.77M | 602.64M |
| Account Payables | 21.94M | 21.94M | 20.36M | 27.46M | 9.33M |
| Short-term Debt | 147.56M | 147.56M | 57.32M | 26.74M | 5.74M |
| Tax Payables | 1.13M | 161K | 4.05M | 10.11M | 0 |
| Deferred Revenue | 1.74M | 1.74M | 1.69M | 1.07M | 1.27M |
| Other Current Liabilities | 53.73M | 53.73M | 28.4M | 27.87M | 30.12M |
| Total Current Liabilities | 237.75M | 237.75M | 124.84M | 110.23M | 67.1M |
| Long-term Debt | 36.17M | 36.17M | 4.91M | 39.96M | 0 |
| Deferred Tax Liabilities | 16.75M | 16.75M | 16.22M | 1.89M | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 71.3M | 71.3M | 53.69M | 53.32M | 4.21M |
| Total Non-current Liabilities | 166.89M | 166.89M | 112.38M | 132.45M | 22.38M |
| Total Liabilities | 404.64M | 404.64M | 237.22M | 242.67M | 89.49M |
| Common Stock | 6.84B | 6.84B | 6.98B | 6.95B | 7.03B |
| Retained Earnings | (6.29B) | (6.29B) | (6.38B) | (6.33B) | (6.46B) |
| Accumulated OCI | (58.33M) | (58.33M) | (43.78M) | (55.91M) | (214.15M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 31.06M | 31.06M | 42.17M | 41.18M | 0 |
| Total Equity | 521.74M | 521.74M | 602.92M | 605.09M | 513.15M |
| Total Debt | 226.41M | 226.41M | 99.78M | 103.98M | 23.92M |
| Net Debt | (74.45M) | (74.45M) | (79.75M) | (80.28M) | (88.85M) |
Aurora Cannabis Inc.
NASDAQ:ACB
Intrinsic Alpha fair value
Locked
Current Price
$4.40
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.